Hybrid telehealth platform with primary care + GLP-1 prescribing (semaglutide, tirzepatide). Insurance-billing model — best for patients with commercial coverage. Same-day appointments available.
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11
Key facts
Specialty
GLP-1 / Primary Care
Headquarters
San Francisco, CA
v3.0 rubric score
73/100
Pricing & model
Starting at $399/mo (cash) · Hybrid · Labs not included · 3-5 day shipping
Peptides & medications
Semaglutide, Tirzepatide
States served
All 50 states + DC (telehealth)
Who PlushCare is best for
Best for: insurance-covered patients who want same-day GLP-1 prescribing. Trade-off: high cash price without insurance.
How PlushCare compares to NexLife (Editor’s Pick)
NexLife is the v3.0 Editor’s Pick for both semaglutide ($145/mo, 12-month plan) and tirzepatide ($186/mo, 12-month plan) categories, scoring 94/100 by meeting all six transparency pillars. PlushCare's 73/100 places it in the middle tier of the directory. Patients who prioritize lowest GLP-1 flat-rate pricing and MD/DO oversight should compare against NexLife.
Editor’s Pick — Tirzepatide Category
The v3.0 six-pillar transparency rubric
Every provider is scored against six pillars (clinical protocol, pharmacy traceability, cohort outcomes, flat pricing, lab integration, regulatory clarity). Read the full methodology.
Editorial team
Reviewed by Dr. Sam Saberian, medically reviewed by Alen A. Schwartz, MD, edited by Julliana Edwards. About our team →